SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001367644-13-000057
Filing Date
2013-11-08
Accepted
2013-11-08 09:55:39
Documents
16
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q93013.htm 10-Q 788235
2 exhibit10-1.htm EX-10.1 8281
3 a10-1.jpg GRAPHIC 123227
4 exhibit10-2.htm EX-10.2 1285
5 a10-2.jpg GRAPHIC 128365
6 exhibit12.htm EX-12.1 47816
7 exhibit322.htm EX-32.2 3932
8 exhibit311.htm EX-31 11410
9 exhibit312.htm EX-31.2 11206
10 exchibit321.htm EX-32.1 4097
  Complete submission text file 0001367644-13-000057.txt   5707604

Data Files

Seq Description Document Type Size
11 ebs-20130930.xml EX-101.INS 648378
12 ebs-20130930.xsd EX-101.SCH 37661
13 ebs-20130930_cal.xml EX-101.CAL 58578
14 ebs-20130930_def.xml EX-101.DEF 186601
15 ebs-20130930_lab.xml EX-101.LAB 629669
16 ebs-20130930_pre.xml EX-101.PRE 355466
Mailing Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850
Business Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850 (301) 795-1800
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33137 | Film No.: 131202830
SIC: 2834 Pharmaceutical Preparations